Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
Trends in Parasitology
|
March 15, 2021
Genomic and Genetic Approaches to Studying Antimalarial Drug Resistance and Plasmodium Biology
John Okombo, Mariko Kanai, Ioanna Deni, et al.
Journal of Medicinal Chemistry
|
January 9, 2020
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present)
Peter Mubanga Cheuka, Godwin Dziwornu, John Okombo, et al.
Expert Opinion on Therapeutic Patents
|
May 28, 2015
Chloroquine-containing compounds: a patent review (2010 - 2014)
Paul M Njaria, John Okombo, Nicholas M Njuguna, et al.
ACS Infectious Diseases
|
February 4, 2020
Pharmacokinetics and Organ Distribution of C-3 Alkyl Esters as Potential Antimycobacterial Prodrugs of Fusidic Acid
Natasha Strydom, Gurminder Kaur, Godwin Akpeko Dziwornu, et al.
Trends in Parasitology
|
January 9, 2010
Anticancer agents against malaria: time to revisit?
Alexis Nzila, John Okombo, Ruy Perez Becker, et al.
Bioorganic & Medicinal Chemistry
|
May 5, 2020
Structure-activity relationship analyses of fusidic acid derivatives highlight crucial role of the C-21 carboxylic acid moiety to its anti-mycobacterial activity
Kawaljit Singh, Gurminder Kaur, Petrus Siningu Shanika, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
December 18, 2014
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya
John Okombo, Alice W Kamau, Kevin Marsh, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2009
In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation
Steven M Kiara, John Okombo, Victor Masseno, et al.
Antimicrobial Agents and Chemotherapy
|
November 30, 2011
Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya
John Okombo, Steven M Kiara, Leah Mwai, et al.
ACS Infectious Diseases
|
February 21, 2023
Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in <i>Plasmodium falciparum</i>, and Synergize with Clinical Antimalarials
John Okombo, Malkeet Kumar, Devasha Redhi, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
Trends in Parasitology
|
March 15, 2021
Genomic and Genetic Approaches to Studying Antimalarial Drug Resistance and Plasmodium Biology
John Okombo, Mariko Kanai, Ioanna Deni, et al.
Journal of Medicinal Chemistry
|
January 9, 2020
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present)
Peter Mubanga Cheuka, Godwin Dziwornu, John Okombo, et al.
Expert Opinion on Therapeutic Patents
|
May 28, 2015
Chloroquine-containing compounds: a patent review (2010 - 2014)
Paul M Njaria, John Okombo, Nicholas M Njuguna, et al.
ACS Infectious Diseases
|
February 4, 2020
Pharmacokinetics and Organ Distribution of C-3 Alkyl Esters as Potential Antimycobacterial Prodrugs of Fusidic Acid
Natasha Strydom, Gurminder Kaur, Godwin Akpeko Dziwornu, et al.
Trends in Parasitology
|
January 9, 2010
Anticancer agents against malaria: time to revisit?
Alexis Nzila, John Okombo, Ruy Perez Becker, et al.
Bioorganic & Medicinal Chemistry
|
May 5, 2020
Structure-activity relationship analyses of fusidic acid derivatives highlight crucial role of the C-21 carboxylic acid moiety to its anti-mycobacterial activity
Kawaljit Singh, Gurminder Kaur, Petrus Siningu Shanika, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
December 18, 2014
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya
John Okombo, Alice W Kamau, Kevin Marsh, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2009
In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation
Steven M Kiara, John Okombo, Victor Masseno, et al.
Antimicrobial Agents and Chemotherapy
|
November 30, 2011
Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya
John Okombo, Steven M Kiara, Leah Mwai, et al.
ACS Infectious Diseases
|
February 21, 2023
Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in <i>Plasmodium falciparum</i>, and Synergize with Clinical Antimalarials
John Okombo, Malkeet Kumar, Devasha Redhi, et al.
Page
of 7